Journal de signalisation cellulaire
Libre accès

Abstrait

Adaptive Immune Responses to SARS-CoV-2 in Recovered Severe COVID-19 Patients

Gallagher Pie

There is an imperative need to determine the durability of adaptive immunity to SARS-CoV-2. We enumerated SARSCoV-2-reactive CD4+ and CD8+ T cells targeting S1 and M proteins and measured RBD-specific serum IgG over a period of 2-6 months after symptoms onset in a cohort of subjects who had recovered from severe clinical forms of COVID-19.